Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Ebola vaccinations in North Kivu, the role of biobanks in research, and a new Zika vaccine candidate

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

Can a mutant be a medical breakthrough?

The leading bacterial causes of diarrhea are enterotoxigenic Escherichia coli and Shigella, and vaccines against these pathogens could save the lives of up to a half-million children each year.

PATH
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New York global health community comes together to discuss innovative partnerships in R&D

Research!America, a GHTC member, recently hosted an event on global health research and development (R&D) in New York. In this guest post, Mandy Goldberg, MPH, shares highlights from the event.

Research!America
Read More
New project launched in Africa to improve regulatory pathways and deliver better health products

Developing new medical products is a global enterprise, with research and development (R&D) activities spanning national borders and products being introduced in many countries at the same time.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New report stresses strengthened regulatory systems abroad

The Institute of Medicine (IOM) yesterday released a new report that stresses the importance of bolstering regulatory systems abroad in order to improve the safety and quality of medical products circulating around the globe. According to the report, many low- and middle-income countries do not have sufficient regulatory capacity, which limits their ability to oversee medical products such as drugs and vaccines.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we're reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What’s ahead on the Hill

In this feature on Breakthroughs, we provide an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

GHTC
Read More
The US Government and research and development for neglected tropical diseases: Most neglected patients still falling through the cracks

One billion people. That’s roughly how many people live in North America and Europe combined. And that’s also roughly how many people have at least one neglected tropical disease (NTD).

Read More
Recognizing World TB Day and the need for new health tools

As people across the globe celebrate World TB Day this week, several groups are highlighting the fact that the current tools to prevent, test, and treat tuberculosis (TB) are greatly outdated. The world has been “beyond antiquated in our approach” to developing new TB tools.

GHTC
Read More
PATH/Richard Franco
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The beginning of the end

Phil Carroll, senior policy communications associate at PATH, writes about Marc LaForce, recently retired director of the Meningitis Vaccine Project. This post is part of an ongoing effort on Breakthroughs to highlight leaders and heroes in global health research and development (R&D).

PATH
Read More
USAID’s Shah continues leadership in science and innovation

Late last week, USAID Administrator Rajiv Shah released his second annual letter, outlining major issues and initiatives that have shaped the agency since its inception 50 years ago.

GHTC
Read More
A technological renaissance for girls and women

Janna Oberdorf, Director of Communications and Outreach for Women Deliver, writes about the recent “Women Deliver 50” initiative to mark International Women’s Day.

Women Deliver
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Women at the Forefront of AIDS Vaccine Research

Dr. Gaudensia Nzembi Mutua is a research physician at the Kenya AIDS Vaccine Initiative (KAVI). She is based in Nairobi, Kenya. This post originally appeared on the ONE blog.

Kenya AIDS Vaccine Initiative
Read More
Health R&D in New York: Extending lives and driving the economy

Research!America, a member of the GHTC, recently conducted analyses in target states to measure the health and economic impact of global health research and development (R&D), highlighting its benefits for states across the nation and strengthening the evidence base for Congress’ support of federal investments in global health R&D. This is the sixth and last post in a series.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
GHTC
Global Health R&D: A Smart Investment for the US

After attending GHTC’s annual briefing yesterday, it is nearly impossible, and arguably fully impossible, to come up with any reason as to why the US should not invest in global health research and development (R&D).

GHTC
Read More